APOE and Alzheimer disease: Several studies suggested the APOE ε4 genotype to be associated with a faster cognitive decline [66] and clinical progression of AD [30], whereas other studies doubt accelerated deterioration in APOE ε4 carriers [29, 30, 67–70].